Evidence map›Paper›PMID 39743355›Full record

ReviewZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2025

[Strategies of statins for the prevention and treatment of hepatocellular carcinoma].

T Tong, J F Li, L Z Shi, L T Zhang

Abstract readReviewEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Review in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

T TongThe First Clinical Medical College of Lanzhou University, Lanzhou 730000, China.
J F LiThe First Clinical Medical College of Lanzhou University, Lanzhou 730000, China Department of Hepatology & Infectious Diseases, the First Hospital of Lanzhou University, Lanzhou 730000, China.
L Z ShiDepartment of Hepatology & Infectious Diseases, the First Hospital of Lanzhou University, Lanzhou 730000, China.
L T ZhangThe First Clinical Medical College of Lanzhou University, Lanzhou 730000, China Department of Hepatology & Infectious Diseases, the First Hospital of Lanzhou University, Lanzhou 730000, China Institute of Portal Hypertension, the First Hospital of Lanzhou University, Lanzhou 730000, China.

Funding

Gansu Province Joint Scientific Research Fund Program 23JRRA1489, 24JRRA911Gansu Province Key R & D Program Project 22YF7FA085Gansu Provincial Health Industry Science and Technology Innovation Major Research Project GSWSZD2024-11Key Talent Project of Gansu Province Gan Group Tongzi[2024]No.4Medical Education Development Project of Lanzhou University lzuyxcx-2022-131, lzuyxcx-2022-147National Natural Science Foundation of China 82360132
6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) is a kind of malignant tumor with an extremely high morbidity and mortality incidence rate. Although some new progress has been made in recent treatment, the overall prognosis is still poor. Therefore, the prevention and treatment of HCC have important clinical significance. Statin drugs are mainly used for the treatment of hypercholesterolemia and the prevention of cardiovascular and cerebrovascular diseases. In recent years, an increasing number of research results have shown that statins have advantages in preventing the occurrence and improving the prognosis of HCC. This paper reviews the new progress performed in the mechanism of statin drug and the current clinical prevention and treatment for HCC.

Indexed as

Carcinoma, HepatocellularHydroxymethylglutaryl-CoA Reductase InhibitorsLiver NeoplasmsHumansPrognosisHydroxymethylglutaryl-CoA Reductase Inhibitors

Identifiers

PMID39743355
PMCPMC12899230

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.